---
title: "Quipt Home Medical Clears HSR Waiting Period for $3.65 Per Share Acquisition"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/273700923.md"
datetime: "2026-01-26T12:31:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273700923.md)
  - [en](https://longbridge.com/en/news/273700923.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273700923.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/273700923.md) | [English](https://longbridge.com/en/news/273700923.md)


# Quipt Home Medical Clears HSR Waiting Period for $3.65 Per Share Acquisition

Quipt Home Medical Corp. has provided an update on its previously announced agreement under which 1567208 B.C. Ltd., an affiliate of REM Aggregator, LLC, will acquire all outstanding common shares of Quipt for $3.65 per share in cash. The company reported that the required waiting period under U.S. antitrust regulations has expired, satisfying one of the closing conditions for the transaction. Completion of the deal remains subject to other customary closing conditions, including approval by Quipt shareholders. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quipt Home Medical Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-006427), on January 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### 相關股票

- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-HK/quote/XHE.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [SPDR S&P Health (XHS.US)](https://longbridge.com/zh-HK/quote/XHS.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [iShares US Healthcare Providers (IHF.US)](https://longbridge.com/zh-HK/quote/IHF.US.md)
- [Quipt Home Medical (QIPT.US)](https://longbridge.com/zh-HK/quote/QIPT.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md)

## 相關資訊與研究

- [BUZZ-Tempus AI rises after study shows AI-driven alerts improve heart valve treatment](https://longbridge.com/zh-HK/news/281390073.md)
- [Perimeter Posts Record 2025 Revenue and Wins FDA Approval for AI Breast Imaging Device](https://longbridge.com/zh-HK/news/281274047.md)
- [ResMed CFO Brett Sandercock disposes of common shares worth $0.2 million](https://longbridge.com/zh-HK/news/281632265.md)
- [Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update](https://longbridge.com/zh-HK/news/281525623.md)
- [InSilico Medicine Strikes Multi-Billion-Dollar AI Drug Discovery Deal With Eli Lilly](https://longbridge.com/zh-HK/news/280909399.md)